Government Briefs

Soviets Bump Up Against NIH Ceiling The Fogarty International Center's exchange program with the Soviet Union is oversubscribed for the first time in its 18-year history. "In the past, we didn't have a ceiling on the program because we could always count on the Soviets to limit themselves," says Gray Handley, director of international coordination and liaison for the NIH-based exchanges. But perestroika has increased demand for the short-term visits, in which the Soviets pay for the flight over

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Soviets Bump Up Against NIH Ceiling The Fogarty International Center's exchange program with the Soviet Union is oversubscribed for the first time in its 18-year history. "In the past, we didn't have a ceiling on the program because we could always count on the Soviets to limit themselves," says Gray Handley, director of international coordination and liaison for the NIH-based exchanges. But perestroika has increased demand for the short-term visits, in which the Soviets pay for the flight over, and NIH finances in-country costs for the visiting Soviet scientists. The program is still quite small--a total of 30 person-months for this year--but Handley says that NIH would be happy to expand it if given additional funds. The Fogarty center also supports exchanges with almost all of the Eastern European countries, at a total annual cost of $350,000. In addition, it runs a visiting scientist program for researchers wishing to come ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo